VAGA
- Company typePrivate
- Founded2011
- HeadquartersNew York, United States
- Headcount5,001–10,000
- GTM typeB2C
- OfferingServices
VAGA firmographics
Firmographics- Name
- VAGA
- Legal name
- VAGARIGHTS.COM
- Website
- https://vagarights.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Ownership category
- akta.pro rank
VAGA industry classification
Industry- Product category
- Art Therapy & Mental Health Services
- NAICS
- Offices of Mental Health Practitioners (except Physicians) (621330), Independent Artists, Writers, and Performers (7115)
- SIC
- Services-Advertising (7310)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industry
- Cognitive Stimulation & Reminiscence Therapy (Non-Clinical) (HSABAEAH)
Keywords
Where VAGA is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
VAGA business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Technology or R&D, Operations
Revenue model
- Affiliate Marketing: VAGA generates revenue through affiliate partnerships with nootropic supplement manufacturers. The site features detailed product reviews with affiliate links to recommended products. When readers purchase through these links, VAGA earns a commission.
- Art Therapy Services: The organization offers art therapy programs and sessions tailored to patient needs, connecting artists with mental health professionals and psychiatric practitioners.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Art Therapy Sessions - Contact-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
VAGA product offering
Product offeringCore offering
VAGA operates Vagarights.com, an editorial publishing platform that produces in-depth nootropic supplement reviews, mental health and art therapy educational articles, and cognitive enhancement resources, monetized primarily through affiliate commissions from third-party supplement brands. Alongside the content platform, VAGA develops and supports Art Therapy Programs that link artists with mental health professionals and psychiatric practitioners to deliver tailored therapeutic sessions for patients dealing with depression, anxiety, BPD, schizophrenia, OCD, ADHD, addiction, and age-related cognitive decline.
Product overview
VAGA operates as a collective and editorial platform focused on mental health and cognitive enhancement through art therapy and nootropic education. The core offering consists of Vagarights.com, a content publication that provides nootropic supplement reviews, art therapy information, and mental health resources. The organization also develops custom art therapy programs by connecting artists with mental health professionals. The product portfolio centers on editorial content rather than proprietary products, with reviews and guides covering various nootropic supplements and therapeutic approaches.
Differentiator
Problem solved
Functional benefit
Products and services
- Vagarights.com Content Platform An editorial/content publishing platform that publishes in-depth nootropic supplement reviews, comparative buyer guides (e.g., best nootropics for ADHD, anxiety, depression, focus, motivation, BDNF, energy), mental health articles, and educational content on art therapy techniques and cognitive enhancement. Content is consumed free by readers and monetized via affiliate links to third-party nootropic retailers serving individual consumers and biohackers.
- Art Therapy Programs Tailored art therapy programs developed by linking artists with mental health experts and psychiatric practitioners to deliver therapeutic sessions for patients dealing with depression, anxiety, BPD, schizophrenia, OCD, ADHD, addiction/substance abuse, and age-related mild cognitive decline. Services are accessible to individual patients and consumers via the contact page on vagarights.com.
- Nootropic Supplement Reviews and Buying Guides In-depth reviews and comparative buying guides for specific nootropic stacks and supplements (including Mind Lab Pro, Alpha Brain, Nooceptin, Vyvamind, NooCube, Qualia Mind, Quantumind, TruBrain, Neuriva, Gorilla Mind Rush, and Genius Consciousness), covering ingredients, benefits, side effects, value-for-money, and where to buy, consumed primarily by biohacker/nootropic-user readers.
Quantifiable outcome
- Art therapy sessions have been found to improve cognitive performance and memory function in people experiencing mild cognitive impairment after just a few weeks
- +1 more outcomes
Companies that use VAGA
Customer profileSegments3 records
Ideal customer profiles2 records
VAGA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
VAGA partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
VAGA competitors and assessment
Company assessmentBroad incumbents
- Headspace Health: Headspace combines a mental wellness app with clinical mental health care through Headspace Health/Ginger. It is a broader incumbent in digital mental health and a natural comparator for any move by VAGA into structured therapy delivery.
- Verywell Mind: Verywell Mind is a large, established mental health editorial property covering therapy, conditions, and wellness. It competes for the same SEO traffic as VAGA's mental health content but operates as part of a broader portfolio under Dotdash Meredith.
- BetterHelp: BetterHelp is the largest online counseling marketplace, covering the same mental health conditions VAGA's content addresses. It is a relevant incumbent in adjacent digital mental health delivery and a likely downstream referral target for VAGA's audience.
- WebMD: WebMD is a large-scale consumer health information portal covering mental health, supplements, and conditions. It competes broadly for the same health-information search traffic that drives VAGA's organic audience.
Direct peers
- SelfHacked: SelfHacked is a biohacking content platform that publishes research-backed articles on supplements, nootropics, and natural health. It directly mirrors VAGA's content-led GTM combining supplement reviews with health optimization editorial, monetized largely through affiliate referrals.
- Psych Central: Psych Central is a long-standing mental health information site covering depression, anxiety, OCD, ADHD, BPD, and schizophrenia. It overlaps with VAGA's editorial coverage of mental health conditions and its consumer mental health audience.
- Examine.com: Examine.com is a supplement and nootropic research database that publishes independent, evidence-based analysis of cognitive enhancement compounds. It is directly comparable to VAGA's nootropics review and guide content and serves the same biohacker/consumer persona.
Emerging players
- Onnit Labs: Onnit is a supplement and nootropics brand (Alpha Brain) that combines product sales with content and education around cognitive performance. It is comparable to VAGA on the nootropics editorial side but is a manufacturer rather than an affiliate publisher.
- Talkspace: Talkspace is a digital therapy platform that delivers online counseling for depression, anxiety, ADHD, and related conditions. It represents the service-side evolution path available to VAGA's art therapy offering if it converts editorial demand into clinical delivery.
- Nootropics Depot: Nootropics Depot is a retailer and educator of cognitive enhancement supplements that combines product sales with educational content. It competes with VAGA for the biohacker persona but operates on the supply side rather than the affiliate editorial side.
Market position
Strengths4 records
Weaknesses1 record
Competitive moat4 records
Key risks6 records
Key highlights5 records
Customer concentration
VAGA financial estimates
Financial estimateRevenue estimate
Valuation estimate
VAGA leadership team
Management profileNumber of profiles
Profiles2 records
VAGA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VAGA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VAGA
What does VAGA do?
VAGA operates Vagarights.com, an editorial publishing platform that produces in-depth nootropic supplement reviews, mental health and art therapy educational articles, and cognitive enhancement resources, monetized primarily through affiliate commissions from third-party supplement brands. Alongside the content platform, VAGA develops and supports Art Therapy Programs that link artists with mental health professionals and psychiatric practitioners to deliver tailored therapeutic sessions for patients dealing with depression, anxiety, BPD, schizophrenia, OCD, ADHD, addiction, and age-related cognitive decline.
Is VAGA a public or private company?
VAGA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was VAGA founded?
VAGA was founded in 2011. It employs 5,001 to 10,000 people.
Where is VAGA based?
VAGA is headquartered in New York, United States, in the North America region.
How does VAGA make money?
Two revenue lines are on record. Affiliate Marketing is the primary driver. The others are art Therapy Services.
Who are VAGA's main competitors?
Broad incumbents on record are Headspace Health, Verywell Mind, BetterHelp and WebMD. Direct peers are SelfHacked, Psych Central and Examine.com. Emerging players are Onnit Labs, Talkspace and Nootropics Depot.
Does VAGA have an API?
No public API is recorded for VAGA.
What industry is VAGA in?
VAGA's product category is Art Therapy & Mental Health Services. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HSABAEAH, Cognitive Stimulation & Reminiscence Therapy (Non-Clinical). Its NAICS code is 621330 and its SIC code is 7310.